97189 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
ANTI-VPAC1 ANTIBODIES AND THEIR USES
#602COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY OF ORGANOPHOSPHATASES
#603ANTAGONISTS OF PGE2 EP3 RECEPTORS
#604TREATMENT OF POST-MENOPAUSAL AND POST-HYSTERECTOMY MEDIATED COGNITIVE DISORDERS
#605SHRNA-MEDIATED INHIBITION OF EXPRESSION OF ALPHA 1,6-FUCOSYLTRANSFERASE
#606DEGRADED AGONIST ANTIBODY
#607Dual variable domain immunoglobulins and uses thereof
#608GROWTH FACTOR
#609Glucagon receptor antagonists
#610Pharmaceutical compositions containing sc(Fv)2
#611Methods and compositions for treating solid tumors and enhancing tumor vaccines
#612Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
#613Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
#614Auto-antibodies against the melanocortin-4 receptor
#615Fusion proteins for delivery of GDNF to the CNS
#616Method for obtaining G protein-coupled receptor (GPCR) diffraction-quality crystals employing a monoclonal antibody that binds to the third intracellular loop (IL3)
#617Delivery of pharmaceutical agents via the human insulin receptor
#618Methods and compositions for increasing α-L-iduronidase activity in the CNS
#619Compositions and methods relating to glucagon receptor antibodies
#620Method of immunizing animal, composition for immunization, method for producing antibody, method for producing hybridoma and method for producing monoclonal antibody
#621Roles for dual endothelin-1/angiotensin II receptor (Dear) in hypertension and angiogenesis
#622Identification of Agonistic Autoantibodies Associated with Humoral Kidney Rejection
#623Antibodies to the Human Prolactin Receptor
#624ANTIBODIES TO HUMAN SOMATOSTATIN RECEPTOR AND METHODS OF USE
#625Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
#626PRLR-specific antibody and uses thereof
#627Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
#628Therapeutic Agent
#629Fed-batch cell culture methods using non-animal-based hydrolysates
#630Methods for diagnosing and treating CNS disorders by trans-blood-brain barrier delivery of protein compositions
#631Fusion antibodies that cross the blood-brain barrier in both directions
#632Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns
#633Methods for treating inflammation by disrupting MCH-mediated signaling
#634Leptin antagonist and method for quantitative measurement of leptin
#635METHOD FOR SCREENING TRANSCRIPTIONAL COREGULATORY PROTEINS OF TRANSCRIPTION FACTORS, AND ANDROGEN RECEPTOR TRANSCRIPTIONAL COREGULATORY PROTEINS AS TARGETS FOR ANDROGEN RECEPTOR-DEPENDENT DISEASES
#636Methods for inhibiting osteoclastic bone resorption and bone loss comprising administration of an anti-FSH or anti-FSHR antibody
#637Binding partners for the thyrotropin receptor and uses thereof
#638Delivery of pharmaceutical agents via the human insulin receptor
#639Neutralizing human anti-IGFR antibody
#640Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodies
#641Antibodies to the human prolactin receptor
#642Estrogen receptors and methods of use
#643Combination therapy using anti-EGFR antibodies and anti-hormonal agents
#644Method for Making Multispecific Antibodies Having Heteromultimeric and Common Components
#645Method for Making Multispecific Antibodies Having Heteromultimeric and Common Components
#646Treatments which Alleviate Functional Glycosylated Leptin Transport Factor, for Controlling Weight and Obesity
#647Serum Prolactin Binding Protein in Epithelial Carcinoma
#648Nucleic acids encoding and methods of producing fusion proteins
#649Fusion proteins for blood-brain barrier delivery
#650Methods for measuring the insulin receptor α subunit
#651Neutralizing human anti-IGFR antibody
#652Neutralizing human anti-IGFR antibody
#653Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation
#654Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
#655Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
#656Prostaglandin receptor EP1
#657Identification of agonistic autoantibodies
#658Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases
#659Antibody for the thyrotropin receptor and uses thereof
#660Mta1s, a steriod hormone receptor corepressor
#661Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
#662Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer
#663Methods and compositions for control of bone formation via modulation of sympathetic tone
#664Identification of TSH receptor autoantibodies using affinity-purified antibodies
#665Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
#666Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases
#667Antibodies that recognize and bind phosphorylated human androgen receptor and methods of using same
#668Composition and method for modulating somatolactogenic function
#669Methods and compositions for preventing obesity and obesity related disorders
#670Delivery of enzymes to the brain
#671Use of inhibitors of PACAP receptor activity for treatment of overactive bladder and pelvic floor pain syndrome
#672Use of ERRalpha phosphorylation status as a breast cancer biomarker
#673Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
#674DNA encoding androgen receptor fragment
#675Treatments which elevate functional glycosylated leptin trasnport factor, for controlling weight and obesity
#676Methods for identifying active compounds
#677Glycoprotein hormone receptor molecules
#678Compositions and methods for enhancing immune responses mediated by antigen-presenting cells